| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/30/2001 | CA2399259A1 Endometriosis-related markers and uses thereof |
| 08/30/2001 | CA2399241A1 Improved methods for generating catalytic proteins |
| 08/30/2001 | CA2399189A1 Microarray fabrication techniques and apparatus |
| 08/30/2001 | CA2399020A1 Process of purification of hcg and recombinant hcg purified by that method |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | CA2397813A1 Method and reagent for the inhibition of grid |
| 08/30/2001 | CA2397705A1 Compounds related to or derived from gfr.alpha.4 and their use |
| 08/30/2001 | CA2397669A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds |
| 08/30/2001 | CA2370803A1 Methods for identifying a protease inhibitor |
| 08/29/2001 | EP1127943A2 Means and methods for the expression of homologous and heterologous proteins in strains of Rhodococcus |
| 08/29/2001 | EP1127941A1 Novel dna fragment elevating gene expression dose |
| 08/29/2001 | EP1127894A1 Method of diagnosis of transmissible spongiform encephalopathy (TSE) |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127576A1 Uses of NM23-polypeptides in skin and intestinal disorders |
| 08/29/2001 | EP1127487A1 Adult t cell leukemia model animal |
| 08/29/2001 | EP1127486A1 A method for production of a transgenic animal |
| 08/29/2001 | EP1127170A1 Human pan-hcv human monoclonal antibodies |
| 08/29/2001 | EP1127169A1 Detection of negative-strand rna viruses |
| 08/29/2001 | EP1127168A2 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 08/29/2001 | EP1127165A1 Method and test kit for analyzing dns repair |
| 08/29/2001 | EP1127164A1 PHARMACOLOGICAL TARGETING OF mRNA CAP FORMATION |
| 08/29/2001 | EP1127163A2 A method for genomic substractive hybridization |
| 08/29/2001 | EP1127161A1 Method for making complementary oligonucleotide tag sets |
| 08/29/2001 | EP1127160A2 Parallel methods for genomic analysis |
| 08/29/2001 | EP1127159A1 METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSENGER RNAs |
| 08/29/2001 | EP1127158A1 Use of dna identification techniques for the determination of genetic material of cocoa in fermented or roasted beans and chocolate |
| 08/29/2001 | EP1127157A1 METHYLATED CpG ISLAND AMPLIFICATION (MCA) |
| 08/29/2001 | EP1127152A1 A method of recombination and agents useful for same |
| 08/29/2001 | EP1127151A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 08/29/2001 | EP1127150A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 08/29/2001 | EP1127149A2 Cells for the production of helper dependent adenoviral vectors |
| 08/29/2001 | EP1127147A2 Plant proteins that interact with nuclear matrix proteins and function as transcriptional activators |
| 08/29/2001 | EP1127146A2 Novel expression cassette for expressing genes in plant seed |
| 08/29/2001 | EP1127145A2 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(AGROBACTERIUM VITIS) |
| 08/29/2001 | EP1127144A2 Plant glutamine amidotransferase homologs |
| 08/29/2001 | EP1127143A2 Dna comprising rice anther-specific gene and transgenic plant transformed therewith |
| 08/29/2001 | EP1127142A1 Modulation of polypeptide display on modified filamentous phage |
| 08/29/2001 | EP1127141A1 Method for expressing recombinant proteins using the effect of stress and stress response mechanisms in the presence of compatible solutes |
| 08/29/2001 | EP1127140A2 Fk506-based regulation of biological events |
| 08/29/2001 | EP1127139A2 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists |
| 08/29/2001 | EP1127138A1 Alpha 1,2 fucosyltransferase from helicobacter pylori |
| 08/29/2001 | EP1127137A1 Lps with reduced toxicity from genetically modified gram negative bacteria |
| 08/29/2001 | EP1127136A1 Delivery of superoxide dismutase to neuronal cells |
| 08/29/2001 | EP1127135A2 High fidelity thermostable ligase and uses thereof |
| 08/29/2001 | EP1127134A1 Rotavirus subunit vaccine |
| 08/29/2001 | EP1127133A2 Polypeptide mediating cell permeability |
| 08/29/2001 | EP1127132A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127130A1 Murine expression of human immunoglobulin lambda locus |
| 08/29/2001 | EP1127129A1 Myosin heavy chain homolog |
| 08/29/2001 | EP1127128A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 08/29/2001 | EP1127127A1 Regulator of notch signaling activity |
| 08/29/2001 | EP1127126A1 G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof |
| 08/29/2001 | EP1127125A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 08/29/2001 | EP1127124A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/29/2001 | EP1127123A2 Cell surface glycoproteins |
| 08/29/2001 | EP1127121A2 Construction of retrovirus with the streptomyces mel locus expressible in mammalian cells |
| 08/29/2001 | EP1127120A1 Genomic and complete cdna sequences of human adipocyte-specific apm1 and biallelic markers thereof |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127118A1 Human gs protein regulator gene |
| 08/29/2001 | EP1127117A1 Opg fusion protein compositions and methods |
| 08/29/2001 | EP1127116A2 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 08/29/2001 | EP1127115A1 Antisense oligomer |
| 08/29/2001 | EP1127114A1 Method of isolating plasmid dna |
| 08/29/2001 | EP1127113A2 Transgenic and cloned mammals |
| 08/29/2001 | EP1127112A2 Methods for cloning animals |
| 08/29/2001 | EP1127110A1 Modified exosomes and uses |
| 08/29/2001 | EP1127109A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 08/29/2001 | EP1127106A1 Glufosinate tolerant rice |
| 08/29/2001 | EP1127105A1 Plants having enhanced gall resistance and methods and compositions for producing same |
| 08/29/2001 | EP1127104A1 Method for the massive culture of cells producing recombinant human erythropoietin |
| 08/29/2001 | EP1127103A1 Recombinant extracellular chitinases and uses thereof |
| 08/29/2001 | EP1127076A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 08/29/2001 | EP1127075A2 A method of treating tumors using fas-induced apoptosis |
| 08/29/2001 | EP1127073A1 Human potassium channel (h-traak) |
| 08/29/2001 | EP1127072A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 08/29/2001 | EP1127070A2 $i(IKAROS) ISOFORMS AND MUTANTS |
| 08/29/2001 | EP1127069A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 08/29/2001 | EP1127068A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 08/29/2001 | EP1127067A2 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 08/29/2001 | EP1127066A1 Modified proteins |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP1127064A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 08/29/2001 | EP1126912A1 Method and device for carrying out biochemical reactions with a high throughput |
| 08/29/2001 | EP1126878A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 08/29/2001 | EP1126877A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 08/29/2001 | EP1126870A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 08/29/2001 | EP1126869A2 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 08/29/2001 | EP1126866A2 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| 08/29/2001 | EP1126865A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 08/29/2001 | EP1126863A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 08/29/2001 | EP1126858A1 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 08/29/2001 | EP1126824A1 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 08/29/2001 | EP1126756A1 Herbicide resistant rice |
| 08/29/2001 | EP1000089A4 Collagen type i and type iii adhesive compositions |
| 08/29/2001 | EP0932700B1 Method of sequencing dna |
| 08/29/2001 | EP0792290B1 Acylated insulin |
| 08/29/2001 | EP0778899A4 Enrichment of fetal cells from maternal blood |
| 08/29/2001 | EP0754754B1 Fk506-binding protein gene |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |